ADULT L2 ACUTE LYMPHOBLASTIC LEUKEMIA

Clinical trials for ADULT L2 ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new ADULT L2 ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for ADULT L2 ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Intensive combo therapy tested in High-Risk leukemia

Disease control Ongoing

This study tested a multi-part treatment for adults with a specific, aggressive type of acute lymphoblastic leukemia (ALL). The goal was to see if combining intensive chemotherapy, a targeted drug called dasatinib, and for some patients, a stem cell transplant from a donor, could…

Matched conditions: ADULT L2 ACUTE LYMPHOBLASTIC LEUKEMIA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:40 UTC

ADULT L2 ACUTE LYMPHOBLASTIC LEUKEMIA

Get alerted when new ADULT L2 ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

Intensive combo therapy tested in High-Risk leukemia